Listen " Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs "
Episode Synopsis
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.
Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics.
Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
More episodes of the podcast DeviceTalks Podcast Network
May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US
19/12/2025
Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD
12/12/2025
How Enovis is unlocking better bracing with innovative materials, patient comfort & next-gen tech
09/12/2025
How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care
05/12/2025
Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi
26/11/2025
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.